REGULATION OF SECRETION BY VASOACTIVE-INTESTINAL-PEPTIDE IN ISOLATED PERFUSED RAT SUBMANDIBULAR GLANDS

被引:14
|
作者
TURNER, JT
CAMDEN, JM
机构
[1] Department of Pharmacology, School of Medicine, University of Missouri-Columbia, Columbia
关键词
STIMULUS-SECRETION COUPLING; SYNERGISM; VIP;
D O I
10.1016/0003-9969(92)90050-I
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The isolated, perfused gland was used to examine the regulation of saliva volume and protein content by vasoactive intestinal peptide (VIP). In the absence of other secretagogues, VIP produced a modest, sustained saliva flow with a biphasic dose-response curve in which saliva volume was greatest at 1 nM VIP (28.5 +/- 3.8-mu-l in the first 5 min, n = 4) but reduced at lower and higher concentrations. The protein concentration in saliva released in response to VIP (0.86 +/- 0.13-mu-g/mu-l) was substantially higher than with 30 nM acetylcholine (0.06 +/- 0.02-mu-g/mu-l) or 1 nM substance P (0.30 +/- 0.05-mu-g/mu-l). During the first 5 min of stimulation, VIP and substance P were synergistic in terms of volume and protein content whereas inclusion of VIP did not increase acetylcholine-stimulated flow in the first 5 min but produced a higher sustained flow over the next hour. After stimulation with acetylcholine, subsequent addition of VIP transiently enhanced saliva volume and protein content in a monophasic, dose-dependent manner with effects at 1 pM VIP and higher. The responses were different for VIP compared with other cAMP-mobilizing agents and the involvement of multiple VIP receptor subtypes was suggested from experiments in which a VIP antagonist blocked the VIP enhancement of saliva volume but not the increase in protein.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 50 条
  • [21] IS VASOACTIVE-INTESTINAL-PEPTIDE (VIP) SIGNIFICANTLY NATRIURETIC IN THE RAT
    LONERGAN, MA
    FIELD, MJ
    [J]. KIDNEY INTERNATIONAL, 1991, 40 (03) : 571 - 571
  • [22] VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR ANTAGONISM INHIBITS PROLACTIN SECRETION
    SAMSON, WK
    BIANCHI, R
    RAMOS, E
    VALE, W
    RIVIER, J
    [J]. FEDERATION PROCEEDINGS, 1987, 46 (03) : 1062 - 1062
  • [23] GLYCOGENOLYTIC EFFECT OF VASOACTIVE-INTESTINAL-PEPTIDE IN THE RAT INVIVO
    SANCHEZ, V
    GOBERNA, R
    CALVO, JR
    [J]. EXPERIENTIA, 1991, 47 (06): : 625 - 626
  • [24] EFFECTS OF VASOACTIVE-INTESTINAL-PEPTIDE AND ITS HOMOLOGS ON THE NORADRENALINE-MEDIATED SECRETION OF FLUID AND PROTEIN FROM THE RAT SUBMANDIBULAR-GLAND
    IWABUCHI, Y
    MASUHARA, T
    [J]. GENERAL PHARMACOLOGY, 1994, 25 (07): : 1427 - 1434
  • [25] EFFECTS OF VASOACTIVE-INTESTINAL-PEPTIDE AND ITS HOMOLOGS ON THE ACETYLCHOLINE-MEDIATED SECRETION OF FLUID AND PROTEIN FROM THE RAT SUBMANDIBULAR-GLAND
    IWABUCHI, Y
    MASUHARA, T
    [J]. GENERAL PHARMACOLOGY, 1995, 26 (05): : 961 - 970
  • [26] RECEPTORS FOR VASOACTIVE-INTESTINAL-PEPTIDE IN RAT ANTERIOR-PITUITARY GLANDS - LOCALIZATION OF BINDING TO LACTOTROPES
    WANKE, IE
    RORSTAD, OP
    [J]. ENDOCRINOLOGY, 1990, 126 (04) : 1981 - 1988
  • [27] Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart
    Sawmiller, DR
    Henning, RJ
    Cuevas, J
    DeHaven, WI
    Vesely, DL
    [J]. NEUROPEPTIDES, 2004, 38 (05) : 289 - 297
  • [28] EFFECT OF VASOACTIVE INTESTINAL PEPTIDE (VIP) IN ISOLATED PERFUSED RAT-KIDNEY
    ROSA, R
    STOFF, JS
    SILVA, P
    EPSTEIN, FH
    [J]. KIDNEY INTERNATIONAL, 1977, 12 (06) : 571 - 571
  • [29] Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart
    Sawmiller, DR
    Henning, R
    Vesely, D
    Dehaven, W
    [J]. FASEB JOURNAL, 2002, 16 (04): : A570 - A570
  • [30] INHIBITION OF GLUCOSE-OXIDATION IN ISOLATED ENTEROCYTES OF THE RAT BY THE VASOACTIVE-INTESTINAL-PEPTIDE (VIP)
    VIDAL, H
    COMTE, B
    BEYLOT, M
    RIOU, JP
    [J]. DIABETES & METABOLISM, 1987, 13 (04): : 493 - 493